906 followers
New article: Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity. https://t.co/KkGzRzC38Z #melanoma #oncology https://t.co/8a5YQUCQB7
New article: Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity. https://t.co/KkGzRzC38Z #melanoma #oncology https://t.co/8a5YQUCQB7
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity. by Cheli Y, Tulic MK, El Hachem N, Nottet N, Jacquel A, Gesson M, Strub T, Bille K, Picard-Gauci A, Montaudié H, B…